Division of Hematology and Oncology Archive — Page 2 of 15

(AdobeStock)
October 14, 2025

VUMC researchers awarded $2 million to expand AI-powered medical record abstraction

The grant extension will expand applications in research, clinical trials, registries and national collaborations.

Among those in Washington, D.C., were, from left, Nicholas Warren, Shelagh Mulvaney, PhD, Alvin Powers, MD, Patrick Hu, MD, PhD, Hyun Song, PhD, Ronald McMillan, PhD, and Sara Kavanaugh.
September 25, 2025

Vanderbilt scientists advocate for NIH funding in Congress

Scientists from Vanderbilt University Medical Center and Vanderbilt University joined other advocates from Tennessee to share why continued bipartisan support for NIH is important to them.

By Nicholas Warren
Megan Dupuis, MD, PhD
August 14, 2025

Megan Dupuis named Internal Medicine Residency Program director

Beginning in July 2026, Dupuis will coordinate all aspects of the internal medicine residency, including the interview and selection process, mentoring the residents going through the program.

By Jill Clendening
August 1, 2025

Study reports final clinical trial data for advanced kidney cancer treatment

The drug combo pembrolizumab plus axitinib had sustained and durable clinical benefit in more than five years of follow-up. It is a standard-of-care first-line treatment for advanced kidney cancer.

By Leigh MacMillan
May 30, 2025

Andreana Holowatyj named ‘40 Under 40 In Cancer’ winner

The awards initiative identifies and recognizes contributions across the field of cancer by rising stars and emerging leaders under the age of 40.

By Tom Wilemon
Kimberly Dahlman, PhD
April 23, 2025

Kimberly Dahlman elected to board of International Association of Medical Science Educators 

She will begin serving her three-year term upon the closing of the association’s annual conference on June 17.

By Tom Wilemon